TNL Mediagene

As of December 31, 2025, TNL Mediagene carries a market capitalization of 55.83M, placing it among publicly traded companies globally. Its enterprise value stands at 74.54M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, TNL Mediagene has 2.56M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, TNL Mediagene maintains a current ratio of 0.50, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, TNL Mediagene's stock has declined approximately 94.50% over the past 52 weeks. The 50-day moving average sits at 3.67, while the 200-day moving average is 10.15.

As of December 31, 2025, TNL Mediagene holds 2.91M in cash and equivalents against 21.62M in total debt, resulting in a net debt position of 15.87M. Total book value stands at 919,255.00, with working capital of -17.45M providing operational flexibility.

TNL Mediagene's most recent stock split took place on September 8, 2026 with a 8:1 split ratio.